Damian McNamara is a journalist for Medscape Medical News and MDedge. He worked full-time for MDedge as the Miami Bureau covering a dozen medical specialties during 2001-2012, then as a freelancer for Medscape and MDedge, before being hired on staff by Medscape in 2018. Now the two companies are one. He uses what he learned in school – Damian has a BS in chemistry and an MS in science, health and environmental reporting/journalism. He works out of a home office in Miami, with a 100-pound chocolate lab known to snore under his desk during work hours.
News
Study highlights need to investigate psoriasis treatment outcomes in skin of color patients
- Author:
- Damian McNamara
MIAMI – Researchers used phase 2 and 3 psoriasis clinical trial data to explore potential differences in treatment response in various ethnic...
News
Alemtuzumab-induced autoimmunity: getting closer to answers
- Author:
- Damian McNamara
Researchers are getting closer to identifying MS patients more susceptible to secondary autoimmunity after alemtuzumab treatment.
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Image/February-2018/130855_Repovic_Pavle_web.jpg)
Researchers find predictors of worse MS outcomes in post hoc study of three trials
- Author:
- Damian McNamara
Predicting which people with MS might experience relapse or progression of disability could help clinicians more closely follow those at higher...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Image/February-2018/130733_Hunter_Samuel_web.jpg)
Fingolimod switch from an injectable linked to improved outcomes in relapsing MS
- Author:
- Damian McNamara
SAN DIEGO – The benefit of the switch was observed regardless of previous treatment status.
Aesthetic Dermatology
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Image/February-2018/130470_Cohen_Joel_L_web.jpg)
Set realistic expectations prior to perioral rejuvenation procedures
- Author:
- Damian McNamara
MIAMI – For major perioral lines, an “orange peel” texture, and/or elastotic changes, laser resurfacing can be an appropriate option.
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Image/February-2018/Tsao_Hensin_BOSTON_web.jpg)
Be alert for BAP1 mutations in hereditary melanomas
- Author:
- Damian McNamara
MIAMI – They’re rare genetic mutations that can make melanoma more aggressive and lethal, as well as signal of a potentially elevated risk for...
Video
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Image/February-2018/coles.jpg)
VIDEO: Managing the alemtuzumab paradox
- Author:
- Damian McNamara
SAN DIEGO – Dr. Alasdair Coles explains the best management approach for this “high risk, high gain” drug.
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Image/February-2018/Bass_Ann_D_TEXAS_1_web.jpg)
Third course of alemtuzumab can improve MS outcomes
- Author:
- Damian McNamara
SAN DIEGO – Patients who experience radiographic relapse after two courses of alemtuzumab may not be treatment failures.
Video
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Image/February-2018/evans_0.jpg)
VIDEO: New MS ambulatory measure could fill clinical gap
- Author:
- Damian McNamara
SAN DIEGO – Dr. Emily Evans explains how the single-item instruments measure up to existing ambulatory scales.
Video
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Image/February-2018/screenshot_1.jpg)
VIDEO: Alemtuzumab associated with long-term MS control in TOPAZ study
- Author:
- Damian McNamara
SAN DIEGO – Extension study reveals durable benefit at 7 years.
Video
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Image/February-2018/screenshot_91.jpg)
VIDEO: Could targeting gut dysbiosis in MS prevent disease?
- Author:
- Damian McNamara
SAN DIEGO – Transgenic mouse studies lead to questions of altering gut flora to prevent disease in people at high risk for multiple sclerosis.
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Image/February-2018/Chitnis_Tanuja_MA_web.jpg)
Fingolimod cuts pediatric MS relapse rate more than interferon beta-1a
- Author:
- Damian McNamara
The PARADIGMS study is the first international controlled trial to test fingolimod in pediatric patients.
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Image/January-2018/Keaney_Terrence_DC_web2.jpg)
Want to expand aesthetic dermatology business? Appeal to men
- Author:
- Damian McNamara
Bringing in more male patients to an aesthetic dermatology practice can deliver a long-term payoff in loyalty and return business.
News
Best practices address latest trends in PDT, skin cancer treatment
- Author:
- Damian McNamara
MIAMI – Consider new CPT codes for PDT and the benefit of hedgehog inhibitors to shrink some skin cancers before further treatment.
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Image/January-2018/Kirsner_Robert_S_Miami_web.jpg)
Five pearls target wound healing
- Author:
- Damian McNamara
MIAMI – Recent evidence in the literature counters conventional wisdom on wound closure, and provides other clinical tips to foster better wound...